CTIBiotech

CTIBIOTECH offers predictive human cell bioassays for preclinical trials, tailored for pharmaceutical industry and research institutions.

Every skin is unique, and the skin of the youngest deserves special care.

CTIBIOTECH’s international distribution network provides human tissue models, 3D cell culture products, and preclinical testing solutions through certified biotech distributors.

CTIBIOTECH won the Life Sciences award in the final of the WORLD TOP-PERFORMING INCUBATOR CONFERENCE, in Shanghai, CHINA, 2024.

CTIBIOTECH presents CTISKIN at In-Cosmetics Amsterdam 2025, showcasing efficacy testing using ex vivo biopsies, in vitro cell cultures, and 3D bioprinted models.

World's first computer-connected lab grown human bioprinted skin: CTISKIN by CTIBIOTECH Sweeps Awards at IFSCC 2025 Congress with Groundbreaking Bioprinted Skin Technology

CTIBIOTECH operates biotech facilities with cell culture labs, biobanks, and 3D bioprinting to support preclinical research and drug development for biotech and pharmaceutical companies.

CTIBIOTECH’s governance framework ensures regulatory compliance, data integrity, and responsible innovation in biotech and pharmaceutical research.

CTIBIOTECH accelerates drug development and preclinical research using advanced biotech innovation, ISO-certified quality standards, and trusted partnerships.

CTIBIOTECH provides investor resources, financial updates, corporate governance, and strategic growth information, along with details on ethical standards and biotech platforms.

Since 2009, CTIBIOTECH has developed advanced human models for biomedical research and the pharmaceutical sector, offering alternatives to animal testing.